BLU
$5.77
Bellus Health
$.31
5.68%
BLU
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  ($0.28)
Revenue:  $0.01 Mil
Wednesday
Feb 9
4:30 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when BLU reports earnings?
Beat
Meet
Miss

Where is BLU's stock price going from here?
Up
Flat
Down
Stock chart of BLU
Analysts
Summary of analysts' recommendations for BLU
Score
Grade
Pivots
Resistance
$6.40
$6.19
$5.83

$5.62

Support
$5.25
$5.04
$4.68
Tweet
Growth
Description
BELLUS Health is a global health company focused on the development and commercialization of products to provide innovative health solutions to address critical unmet medical needs.